-
www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/cognitive-impairment-older-adults
March 06, 2025 - , family/caregiver, or safety outcomes? … , family/caregiver, or safety outcomes? … Goal-concordant care: Healthcare, legal, and financial planning and decision making (e.g., advanced directives); safety … Cognitive function
Function: ADLs, IADLs, global function
Dementia-related symptoms/behaviors
Safety … life
Global stress/distress
Caregiver burden
Depression
Anxiety
Societal outcomes :
Safety
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/cognitive-impairment-older-adults
June 12, 2025 - , family/caregiver, or safety outcomes? … , family/caregiver, or safety outcomes? … Goal-concordant care: Healthcare, legal, and financial planning and decision making (e.g., advanced directives); safety … Cognitive function
Function: ADLs, IADLs, global function
Dementia-related symptoms/behaviors
Safety … life
Global stress/distress
Caregiver burden
Depression
Anxiety
Societal outcomes :
Safety
-
www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/current-members/ericka-gibson-md-mph
January 01, 2025 - As the physician program director for perinatal safety and quality, she works to ensure that patients … program design and implementation, protocol development and dissemination, quality improvement, and safety … Gibson is a practicing obstetrician-gynecologist and sees patients at the Cumberland Medical Office building … Gibson leads the Perinatal Patient Safety team at the Southeast Permanente Medical Group, establishing … other maternal-child health leaders to analyze research on maternal health, postpartum care, remote patient
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/cognitive-impairment-in-older-adults-screening
October 19, 2017 - KQs 4, 5: Active intervention
Outcomes
KQs 1, 4: Decisionmaking outcomes:
For patients … and family/caregivers: Health care, legal, and financial planning (e.g., advanced directives); safety … and caregiver education; safety planning; monitored medication use; screening and diagnostic decisions … (e.g., neuropsychiatric disturbances, insomnia, depression, agitation, verbal aggression, apathy)
Safety … of life
Global stress/distress
Caregiver burden
Depression
Anxiety
Societal outcomes: Safety
-
www.uspreventiveservicestaskforce.org/uspstf/announcements/us-preventive-services-task-force-announces-addition-two-new-members
January 01, 2025 - As the physician program director for perinatal safety and quality, she works to ensure that patients … program design and implementation, protocol development and dissemination, quality improvement, and safety
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/-wqedxmwdpdE5BmzcBeTmn
December 01, 2009 - than 30
years, is important both for safety and to ensure optimal treatment. … The case manager also provided patient education and
follow-up. … Committee on Safety of Medicines. … Efficacy and safety of triiodothyronine supplemen-
tation in patients with major depressive disorder … Paroxetine: safety and tolerability issues. Expert Opin Drug Saf. 2008;7:783-94.
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/obesity-in-adults-screening-and-management-2012
June 15, 2012 - evidence suggests that waist circumference may be an acceptable alternative to BMI measurement in some patient … Clinicians should understand the evidence but individualize decision making to the specific patient or … has a BMI of 40 kg/m 2 or higher, or the patient has a BMI of 35 kg/m 2 or higher and comorbid medical … FDA Drug Safety Communication: Completed Safety Review of Xenical/Alli (Orlistat) and Severe Liver Injury … Accessed at https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fda-drug-safety-communication-completed-safety-review-xenicalalli-orlistat-and-severe-liver-injury
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/hepatitis-c-screening
March 02, 2020 - Efficacy and safety of glecaprevir/pibrentasvir in patients with chronic hepatitis C virus genotype 5 … Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 1 hepatitis … Efficacy and safety of ombitasvir, paritaprevir, and ritonavir in an open-label study of patients with … Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 2 hepatitis … Sofosbuvir and velpatasvir combination improves patient-reported outcomes for patients with HCV infection
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/T6Tquunynv3tWM65BFash2
October 01, 2015 - with established effectiveness and
safety (previously stated). … with established effectiveness
and safety (previously stated). … Chantix (varenicline): safety
communication—updated safety review on the risk of cardiovascular
adverse … Tobacco-
cessation patient counseling. Am J Prev Med. 1998;15:160-2. [PMID:
9713673]
45. … professional judgment
and patient preferences.
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/chronic-obstructive-pulmonary-disease-screening
October 08, 2020 - *Includes asymptomatic adults, adults who have physical symptoms that are undetected by the patient … important evidence gaps from the prior review (i.e., effects of screening for or early treatment of COPD on patient … years and older, asymptomatic adults, adults who have physical symptoms that are undetected by the patient … ; pregnant women
KQs 2, 3: Patients with severe or very severe COPD; pregnant women; patients with … Study Designs
KQs 1, 2: RCTs
KQ 3: RCTS included for KQ2, large registry studies of drug safety
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/cAs__BR8J4rgcZ4vQgfaTx
April 01, 2009 - at increased risk
when you judge that the benefits to the individual patient
outweigh the potential … How should providers approach screening
in patients at increased risk? … y Select occupations, such as pilots, where sudden incapacitation or sudden
death may endanger the safety … the benefits to the individual patient
outweigh the harms. … Does the patient have signs or symptoms of CHD?
y If so, consider a diagnostic evaluation.
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-screening-for-familial-hypercholesterolemia/lipid-disorders-in-children-screening-july-2016
August 09, 2016 - Health outcomes (KQ1, KQ5, and KQ8) were defined as those experienced by the patient. … Participants in the included statin trials were patients at tertiary care centers; none of the studies … Further consideration of genetic mutation status in treatment response and outcomes for patients with … Mean % Change (SD)
No. of Patients
Mean % Change (SD)
Pravastatin
Knipscheer et al … a Studies included for KQ7 involved 2210 patients, 2197 of whom had FH.
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis-june-2019
June 11, 2019 - there were no HIV infections or results were combined with daily PrEP. 21 , 39 In all trials, all patients … What is the diagnostic accuracy of provider or patient risk assessment tools in identifying individuals … The number of participants with seroconversion in each study was small (1 to 4 patients per study). … Duration of
Follow-up
Interventions b
HIV Risk Group;
Risk-Based Inclusion Criteria
Patient … c Sample of patient who reported that they were taking PrEP.
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/intimate-partner-violence-and-abuse-of-elderly-and-vulnerable-adults-screening-2013
January 15, 2013 - Clinicians should understand the evidence but individualize decision making to the specific patient or … Clinical Considerations
Patient … Counseling generally includes information on safety behaviors and community resources. … of their patients. … The counseling emphasized safety behaviors and information on community resources.
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/two-new-tf-members-announcement-bulletin.pdf
January 16, 2025 - As the physician program director for perinatal safety and quality, she works to
ensure that patients … program
design and implementation, protocol development and dissemination, quality improvement, and safety
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/njteJ388DLVsY8RLcBTe_A
February 25, 2020 - planning, including advance directives;
safety planning; legal and financial planning); patient health … Efficacy,
safety and tolerability of rivastigmine capsules in
patients with probable vascular dementia … The efficacy and safety of donepezil in
patients with Alzheimer’s disease: results of a US
multicentre … Efficacy
and safety of rivastigmine in patients with
Alzheimer’s disease: international randomised
controlled … Efficacy and
safety of galantamine in patients with mild to
moderate Alzheimer’s disease: multicentre
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/cognitive-impairment-in-older-adults-screening
February 25, 2020 - planning, including advance directives; safety planning; legal and financial planning); patient health … Efficacy, safety and tolerability of rivastigmine capsules in patients with probable vascular dementia … The efficacy and safety of donepezil in patients with Alzheimer’s disease: results of a US multicentre … Efficacy and safety of rivastigmine in patients with Alzheimer’s disease: international randomised controlled … Efficacy and safety of galantamine in patients with mild to moderate Alzheimer’s disease: multicentre
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/dCH2CMqVyAzf4eyj-ch6H3
August 09, 2016 - Health outcomes (KQ1, KQ5, and KQ8) were defined as those
experienced by the patient. … –50 –10 10–20 0
Group Difference, Mean % Change (95% CI)
–30–40
LDL-CholesterolA
Placebo
No. of
Patients … Participants in the included statin trials
were patients at tertiary care centers; none of the studies … Further consideration of genetic mutation status in treatment re-
sponse and outcomes for patients with … Use of
low-density lipoprotein cholesterol gene score to
distinguish patients with polygenic and monogenic
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/fUBAvD-8M4xWhBsdqvpsvf
January 01, 2021 - Clinicians should understand the evidence but individualize decision making to the specific patient or … Clinicians should direct patients to other cessation interventions with proven
effectiveness and established … safety
To whom does this recommendation apply? … Clinicians should understand the evidence but individualize decision making to the specific patient or
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review55/genital-herpes-screening-2005
March 15, 2005 - Safety profiles for all treatments were comparable. … Safety profiles were comparable between groups. … Safety profiles between groups were comparable. … The study did not examine safety of the neonate. … The study did not examine safety of the neonate.